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Eukaryotic organisms have developed elaborate mecha- 
nisms to ensure that gene expression is tightly regulated, 
thereby allowing only certain genes to be expressed in 
response to a particular developmental or extracellular 
signal. This selective expression of genes is controlled 
primarily by the activation of gene-specific transcription 
factors that can regulate their target genes both posi- 
tively and negatively. In several cases, preexisting but 
inactive transcription factor complexes are present that 
can be subsequently activated in response to a particular 
signal. One of the most elegant and evolutionarily con- 
served examples of this class is provided by transcription 
factors belonging to the Rel family, which includes the 
mammalian NF-KB and the Drosophila Dorsal proteins. 
NF-KB was identified initially as a heterodimer of a 
50-kD protein (pS0) and a 65-kD (p65) protein that was 
bound in the cytoplasm to a cytoplasmic retention pro- 
tein called IKB (for review, see Grilli et al. 1993)(p50 and 
p65 have recently been renamed NFKB1 and RelA, re- 
spectively). Activation of NF-KB, which is induced by 
numerous agents including mitogens and inflammatory 
cytokines, involves its dissociation from IKB, allowing 
free NF-KB to be transported into the nucleus where it 
can regulate genes involved primarily in immune and 
inflammation responses, as well as certain genes in- 
volved in cell proliferation (for review, see Grilli et al. 
1993). Similarly, in Drosophila, the activation of the Toll 
receptor leads to the disruption of the complex between 
the Drosophila IKB homolog, Cactus, and the Dorsal pro- 
tein (Stein et al. 1991; Norris and Manley 1992), allowing 
translocation of Dorsal into the nucleus where it can 
regulate genes involved in the formation of the dorsov- 
entral axis. 
The idea that IKB proteins function as inhibitory cyto- 
plasmic retention proteins has developed from these 
studes. However, recent discoveries and the character- 
ization of novel forms of IKB proteins suggest that cyto- 
plasmic retention may be just one mechanism by which 
these proteins function. 
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The IKB proteins: identification and mechanisms 
of interaction with NF-KB 
Studies carried out several years ago by the Baltimore 
group (Baeuerle and Baltimore 1988a, b) led to the discov- 
ery that NF-KB is regulated through its interaction with 
IKB. It was found that substantial amounts of NF-KB 
were present in the cytoplasm in a form unable to bind to 
DNA and that this inhibition of DNA binding was me- 
diated through association with the IKB protein. More- 
over, the presence of NF-KB in the nucleus was not as- 
sociated with IKB, suggesting that IKB retains NF-KB in 
the cytoplasm (Baeuerle and Baltimore 1988b). Thus, IKB 
interaction with NF-KB seemed to have at least two con- 
sequences: (1) inhibition of DNA binding of NF-KB, and 
(2) retention of NF-KB in the cytoplasm. Purification of 
IKB forms associated with NF-KB revealed the presence of 
two distinct polypeptides of - 3 7  kD and 43 kD, and 
these were named IKBcx and IKB~, respectively (Zabel and 
Baeuerle 1990). Very little is known at present about 
IKB~, and therefore it will not be discussed here. The 
cloning of IKB~ and the avian IKBcx homolog pp40 dem- 
onstrated the presence of structures called ankyrin re- 
peats (Davis et al. 1991; Haskill et al. 1991), previously 
associated with proteins involved in cell growth and dif- 
ferentiation (Lux et al. 1990). Similar repeats were also 
identified in the carboxy-terminal region of the p105 and 
pl00 (NFKB2) precursors of the p50 and p52 subunits of 
NF-KB, respectively, although the functional signifi- 
cance of this relatedness was unclear (also see below). 
Subsequent studies have revealed the existence of sev- 
eral other forms of IKB proteins. Homology searches car- 
ried out using the IKBa cDNA sequence demonstrated 
striking similarities with the bcl-3 oncogene, originally 
identified by its location adjacent to a chromosomal 
breakpoint associated with chronic lymphocytic leuke- 
mia (Ohno et al. 1990). Further experiments established 
Bcl-3 as a member of the IKB family (Hatada et al. 1992). 
A lymphoid cell-specific form of IKB, called IKB% has 
also been identified (Inoue et al. 1992a; Liou et al. 1992). 
The IKB~t mRNA is generated from an independent tran- 
scriptional start site within the p 105 gene and encodes a 
protein that contains the carboxy-terminal ankyrin-con- 
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taining region of p105 (Inoue et al. 1992a). The cloning of 
the Dorsal inhibitor c a c t u s  has also revealed homologies 
to the mammalian IKB proteins (Geisler et al. 1992; Kidd 
1992). In this review we will focus primarily on the 
mammalian forms of IKB proteins. 
Members of the Rel/NF-KB family exist as dimers, and 
thus association with IKBc,, Bcl-3, and IKBy can lead to 
the formation of trimeric or possibly higher order com- 
plexes. A different mechanism of interaction has been 
proposed for the 105-kD (p105) and the 100-kD (pl00/ 
lyt-10) precursors of NF-KB subunits, shown recently to 
function as IKB-like molecules (Rice et al. 1992; Mercu- 
rio et al. 1993; Naumann et al. 1993; Scheinman et al. 
1993). The difference is attributable to the presence of an 
amino-terminal dimerization/Rel homology domain in 
p105 and pl00 (a similar domain is absent in IKBa, Bcl-3, 
and IKBy; see Fig. 1), which can interact with the com- 
plementary regions of NF-KB subunits such as c-Rel and 
p65. The IKB-like function of p105 and pl00 is localized 
to the carboxy-terminal region that can potentially fold 
back to interact with the dimerization/Rel homology do- 
main (see Fig. 2). The carboxy-terminal domains of p105 
and pl00 bear a high degree of homology with other IKB 
proteins, suggesting that the manner of interaction with 
the Rel homology domain is likely to be similar in both 
cases. Moreover, both mechanisms of interaction seem 
to result in similar biological consequences, that is, cy- 
toplasmic retention and inhibition of NF-KB DNA bind- 
ing (although Bcl-3 may be an exception; also see below). 
All IKB proteins identified to date contain ankyrin re- 
peats. A major proportion of the IKBo~, Bcl-3, IKB~, and 
Cactus protein sequences contain ankyrin repeats while 
such repeats are localized to the carboxy-terminal re- 
gions of p 105 and p 100. However, in both cases, ankyrin 
repeats have been shown to be involved in interaction 
with the highly conserved Rel homology region of NF-KB 
family members (Inoue et al. 1992b; Kidd 1992; Nolan 
and Baltimore 1992; Wulczyn et al. 1992; Hatada et al. 
1993), thus establishing these repeats as commonly used 
interaction motifs among these proteins. Unfortunately, 
no high resolution structural information is currently 
available on the nature of interactions between the IKB- 
ankyrin repeats and the Rel homology region of NF-KB 
family members. 
Specificity of IKB proteins for various ReI/NF-KB 
family members 
Recent studies have shown that the different forms of 
IKB proteins may preferentially interact with different 
Apparent 
I~:B proteins Specificity Localization 
I~Ba I v / / / / / # / / / / / ~  I p65,c-Rel cytoplasm 
Bcl-3 i'" v / / / / / / / / / / / / / / A  I p50, p52 nucleus 
I ~ By i v / / / / / / / / / / / / / / .~  i p 5 0 ? cytoplasm ? 
p1051 I ~:-:~-:: ~:-:::.:~:~:~:~ :~.: ~ :~:~: ~:1 r / / / / / / / / . , ' / / / / / / A  n p50,p65,c-Rel cytoplasm 
plO0 I. i::::~:.~i~-~,:.~i~:J.!~:;::~i~:.~:-.:,~i~-!~:~i:;~;] r . , ' / / / / / / . , . . , ' / / / / / /A  I p50,p52,p65,c-Rel cytoplasm 
Rel domain Ankyrin domain 
subunits of NF-KB (see Fig. 1 for summary; for a review of 
NF-KB family members, see Grilli et al. 1993}. Interac- 
tion has generally been determined by the ability of IKB 
proteins to inhibit the DNA binding of NF-KB subunits, 
although the physiological significance of this inhibition 
is not clear (see below). These results suggest that the 
IKBoL form is selective for homodimeric and het- 
erodimeric complexes containing p65 or c-Rel (Baeuerle 
and Baltimore 1989; Beg et al. 1992). On the other hand, 
the Bcl-3 protein is selective for homodimers of p50 or 
p52 (Wulczyn et al. 1992; Bours et al. 1993; Nolan et al. 
1993), although it has been reported that Bcl-3 can also 
inhibit the DNA binding of p50-p65 (Kerr et al. 1992). 
However, titration experiments have demonstrated that 
the amounts of Bcl-3 that strongly inhibit p50 ho- 
modimer DNA binding have no substantial effect on 
p50--p65 heterodimer DNA binding (Nolan et al. 1993). It 
is thus possible that Bcl-3 may inhibit p50-p65 DNA 
binding at relatively higher concentrations than those 
sufficient to inhibit p50 or p52 homodimer DNA bind- 
ing. The specificity of IKB~ is unclear because it has been 
shown to inhibit the DNA binding of p50 homodimers, 
p50-65, and c-Rel (Inoue et al. 1992a). However, indepen- 
dent expression of the carboxy-terminal domain of p105, 
approximately corresponding to IKB~, results in a protein 
that has been shown to preferentially inhibit pS0 ho- 
modimer DNA binding (Liou et al. 1992). The p105 and 
pl00 IKB molecules seem to have little or no specificity 
for particular NF-KB subunits (Rice et al. 1992; Mercurio 
et al. 1993; Scheinman et al. 1993). Thus, complexes of 
p105 with p50, p65, and c-Rel have been detected, and 
complexes of pl00 with p50, p52, p65, and c-Rel have 
also been identified (Rice et al. 1992; Mercurio et al. 
1993; Scheinman et al. 1993). However, the relative 
amounts of different NF-KB subunits bound to p105 or 
p l00 may vary considerably, thereby resulting in the 
preferential formation of specific homo- or hetero- 
dimeric combinations (also see below). 
In the following discussion, we will identify potential 
mechanisms by which IKB proteins may function in the 
regulation of NF-KB family members (including pS0, p65, 
p52, and c-Rel) and how the divergent mechanisms 
brought about by the different IKB forms may help to 
create the complexity necessary for the regulation of NF- 
KB target genes. 
Regulation of NF-KB nuclear transport by IKB proteins 
Recent experiments have demonstrated that IKB~ dis- 
plays the properties of the activity that was originally 
Transcriptional 






Figure 1. A summary of the different prop- 
erties of IKB proteins discussed in this re- 
view. The subcellular localization of IKB~ 
has not been tested directly. Moreover, the 
specificity of IKB~/ is not clear, although it 
may have some preference for p50 ho- 
modimers (for details, see text}. In some 
cases, Bcl-3 may be an inhibitor {see text). 
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Figure 2. The different mechanisms proposed for 
the activation of NF-KB family members and the 
mechanisms by which these proteins can lead to the 
transcriptional activation of target genes through as- 
sociation of both subunits in the dimeric complex to 
DNA. The inhibitory functions of IKBa, p105, and 
pl00 and their roles in the activation of NF-KB are 
shown at left; the ability of Bcl-3 to function as a 
transcriptional coactivator with p50 or p52 ho- 
modimers is shown at right. The stoichiometry of 
one IKBc~ polypeptide associating with a dimeric tar- 
get may not be necessarily correct. As discussed in 
the text, IKBa and the carboxy-terminal ankyrin re- 
peats of p105 and pl00 likely mask the NLSs of Rel 
family members leading to cytoplasmic localization 
as shown. The association of p105 (or pl00) with p65 
does not suggest the exclusive formation of such 
complexes (for details, see text). The processing of 
p100-p65 would lead to a p52-p65 heterodimer. 
defined as Iv, B. Iv, Bot retains NF-KB subunits in the cyto- 
plasm, probably through the masking of their nuclear 
localization signals (NLSs) (Beg et al. 1992; Ganchi et al. 
1992; Zabel et al. 1993). Analysis of the status of IKBoL 
following stimulation of cells with NF-KB inducers re- 
vealed that it disappeared rapidly following treatment 
(see next section), thus unmasking the NLSs and allow- 
ing NF-KB to be transported to the nucleus. The IKBv 
protein, like Iv, B~t, can also retain Rel/NF-KB family 
members in the cytoplasm (Inoue et al. 1992a); however, 
it is presently unclear whether IKB~/is targeted by NF-KB 
inducers in the same manner as IKBa. It is possible that 
Iv, B~, unlike IKBet, does not regulate NF-KB through a 
post-translational mechanism but, rather, through its 
relative abundance in different cell types. For example, it 
has been found that the IKB~/mRNA is fairly abundant in 
preB cells but not in mature B cells (Liou et al. 1992). 
Therefore, down-regulation of the IKB~ message could 
underlie a mechanism by which constitutive NF-KB 
forms are generated in the nuclei of mature B cells. Fur- 
ther experiments need to be performed to determine the 
precise role of IKB~/in the regulation of NF-KB. 
The ability of Bcl-3 to retain NF-KB subunits in the 
cytoplasm has been controversial. It has been shown that 
Bcl-3 is a nuclear protein, both when transfected alone or 
when transfected in the presence of pS0 or p52 (Bours et 
al. 1993; Nolan et al. 1993). However, a study by Nau- 
mann et al. (1993} reports that transfected Bcl-3 is cyto- 
plasmic and that Bcl-3 retains p50 in the cytoplasm. This 
apparent discrepancy may be attributable in part to the 
different methods employed for determining subcellular 
localizations and/or on the amounts of proteins synthe- 
sized in cells following transfections. Studies analyzing 
endogenous Bcl-3 have shown the existence of two forms 
present in nuclei, although only one form appears to be 
cytoplasmic, suggesting that at least some forms of Bcl-3 
are nuclear (Kerr et al. 1992). In addition, in vitro exper- 
iments performed in this study suggest that an amino- 
terminal truncation of Bcl-3 may have a different speci- 
ficity from the full-length protein. 
Recent investigations have shown that p105 and pl00 
can dimerize with other members of the NF-KB family, 
such as c-Rel and p65, through the amino-terminal Rel 
homology region (Rice et al. 1992; Mercurio et al. 1993; 
Scheinman et al. 1993). The carboxy-terminal ankyrin 
repeat-containing half of p105 can potentially fold back 
and interact with its own amino-terminal Rel homology 
region as well as with its NLS (Henkel et al. 1992). Com- 
plexes of p105 or pl00 with other NF-KB subunits are 
therefore likely to be localized to the cytoplasm through 
the masking of their NLSs by the carboxy-terminal 
ankyrin region of these precursors. Thus, masking of the 
NLSs of NF-KB subunits by IKB proteins may represent a 
general mechanism for cytoplasmic retention. Prote- 
olytic removal of the carboxy-terminal half of p105 or 
p 100 would generate an active complex consisting of pS0 
or p52 homodimers or heterodimers with p65 or c-Rel 
(see Fig. 2). Indeed it has been shown that nuclear NF-~B 
present in HIV-1-infected cells may be generated in part 
through the induced processing of p105 (Rivihre et al. 
1991). In addition, it has been demonstrated recently 
that treatment of cells with TPA can lead to the en- 
hanced processing of p105 and pl00 (Mercurio et al. 
1993); the rates of processing of p105 and pl00 were 
found to be different and also varied in different cell 
types (Mercurio et al. 1993). These results suggest that 
the processing of p105 and pl00 may lead to different 
amounts of homodimers and heterodimers at different 
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times following stimulation. However, these mecha- 
nisms are not likely to be responsible for the rapid nu- 
clear appearance of NF-KB, because the processing is rel- 
atively slow. On the other hand, the processed dimeric 
forms of p105 or p l00 with other Rel family members 
may associate with IKBa in the cytoplasm (see Fig. 2). In 
this scenario, p105 and p l00 complexes may be serving 
as a "latent storehouse" for NF-KB in the cytoplasm 
while IKBet-associated complexes may be serving as a 
more "active storehouse" for NF-KB. The eventual nu- 
clear appearance of NF-KB subunits associated with p 105 
and pl00 would therefore require both the processing of 
these precursors and the loss of IKBoL. 
Autoregulation of NF-KB through the transient 
loss and resynthesis of IKB~ 
Stimulation of cells with NF-KB inducers can lead to the 
degradative loss of IKB~ (Beg et al. 1993; Brown et al. 
1993; Cordle et al. 1993; Henkel et al. 1993; Sun et al. 
1993). Five well-established inducers of NF-KB (TNFoL, 
IL-lot, PMA, PMA/PHA, and LPS) all lead to the loss of 
IKB~ and to the concomitant appearance of NF-KB in the 
nucleus. These results indicate that the loss of IKBa is a 
general mechanism for the activation of NF-KB. IKBc~ loss 
was preceded by phosphorylation (Beg et al. 1993; Cordle 
et al. 1993), consistent with in vitro models suggesting 
that phosphorylation of IKB could disrupt its complex 
with NF-KI3 (Shirakawa and Mizel 1989; Ghosh and Bal- 
timore 1990; Kerr et al. 1991). It is important to note, 
however, that the in vivo role of IKBa phosphorylation is 
presently unclear. In the case of the Drosophila Cactus 
protein, phosphorylation does not seem to disrupt its 
complex with Dorsal (Kidd 1992}, suggesting that phos- 
phorylation of this inhibitor may not be responsible for 
its dissociation from Dorsal. However, evidence has 
been presented that phosphorylation of Dorsal by protein 
kinase A may be involved in its activation (Norris and 
Manley 1992), which suggests that phosphorylation of 
other Rel family members may also be involved in their 
regulation. Furthermore, the identification of the pelle 
gene, which encodes a potential protein kinase as an es- 
sential component required for the nuclear transport of 
Dorsal, has provided conclusive evidence for the involve- 
ment of phosphorylation in the activation of a member 
of the Rel family (Shelton and Wasserman 1993). The 
direct substrates for the Pelle kinase, however, have not 
been identified. Interestingly, Pelle is similar to the Raf 
and Mos serine/threonine kinases. 
Interestingly, it has been found that IKB~ is stabilized 
through association with p65 (Scott et al. 1993; Sun et al. 
1993). These results indicate that any free IKBa that may 
be generated, perhaps through phosphorylation, would 
be immediately targeted for degradation. The degrada- 
tion of IKB~ has been proposed to be mediated by chy- 
motrypsin-like proteases because IKI3~ loss can be pre- 
vented in the presence of inhibitors of such enzymes 
(Henkel et al. 1993). Inhibition of chymotrypsin-like en- 
zymes can also block the activation of NF-KB, indicating 
that the loss of IKBo~ is required for NF-KB activation 
(Henkel et al. 1993). An intriguing question remains un- 
answered: How can several apparently unrelated agents 
lead to the loss of IKBc~? Future investigations directed at 
the identification of potential upstream effector mole- 
cules may not only provide answers to this question but 
also help understand the signal transduction pathways 
that can lead to NF-KB activation. In this regard, recent 
studies demonstrate a role for tyrosine kinases, Ras, and 
Raf-1 (Devary et al. 1993; Finco and Baldwin 1993) and 
for an isoform of protein kinase C (Diaz-Meco et al. 1993) 
in the activation of KB site-dependent gene expression 
and of NF-KB DNA-binding activity. 
The IKBc~ protein reappears rapidly following loss, in- 
dicating a potential mechanism for limiting NF-KB acti- 
vation through the renewed synthesis of its inhibitor 
(Beg et al. 1993; Brown et al. 1993; Scott et al. 1993; Sun 
et al. 1993). Furthermore, transient transfection of a plas- 
mid encoding the p65 subunit of NF-KB can lead to an 
induction of the IKBa mRNA, which indicates that NF- 
KB may directly regulate transcription of the IKB~ gene 
(Brown et al. 1993; Scott et al. 1993; Sun et al. 1993). 
Importantly, NF-KB-binding sites have been identified in 
the promoter region of a porcine IKBa-like gene (de Mar- 
tin et al. 1993). The transcriptional activation of the IKBc, 
gene by NF-KB, followed by an increase in the levels of 
IKBa protein, would ensure that NF-KB activation is tran- 
sient, thus preventing chronic expression of NF-KB--re- 
sponsive genes. The promoter of the p105 gene also con- 
tains NF-KB-binding sites, and the p105 mRNA can be 
induced by agents that activate NF-KB (Ten et al. 1992; 
Cogswell et al. 1993}. Thus, the renewed synthesis of 
p105 may be required for its IKB-like function as well as 
to re-establish the cytoplasmic NF-KB pool. 
The IKB proteins as inhibitors of NF-KB DNA binding 
Although the ability of IKB forms to inhibit the DNA 
binding of NF-KB has been well documented, the in vivo 
significance of these results is still unclear. This is partly 
because endogenous IKBa, p105, and pl00 seem to be 
localized to the cytoplasm (Rice et al. 1992; Beg et al. 
1993; Brown et al. 1993; Mercurio et al. 1993; Schein- 
man et al. 1993; Sun et al. 1993), raising the possibility 
that the inhibition of NF-KB DNA binding by these pro- 
teins may merely be a consequence of competition for 
the regions of NF-KB that are involved in DNA binding. 
However, experiments demonstrating that IKBOL can dis- 
rupt preformed NF-KB-DNA complexes has led to the 
suggestion that IKB~ may limit the transcriptional acti- 
vation by NF-KB by actively removing it from KB sites 
(Zabel and Baeuerle 1990). In addition, recent studies 
have shown that exogenously introduced IKBc~ can be 
found in the nucleus as well as in the cytoplasm (Zabel 
et al. 1993). Thus, it is possible that newly synthesized 
IKBc~ may not only inhibit further NF-KB translocation to 
the nucleus but may also enter the nucleus on its own 
and dissociate preformed NF-KB--DNA complexes. 
Therefore, the eventual depletion of active NF-KB from 
nuclei may involve both of these potential mechanisms. 
However, conclusive proof of a nuclear function for IKl3c, 
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would only be obtained by the detection of NF-KB-IKBa 
complexes in the nucleus. The potential role of Bcl-3 as 
an inhibitor of p50 and p52 DNA binding will be dis- 
cussed in the next section. 
Bcl-3: a putative transcriptional activator 
The IKBot, IKBT, p105, and pl00 proteins may inhibit the 
ability of NF-KB to activate target genes transcriptionally 
through retention in the cytoplasm and perhaps by di- 
rectly displacing NF-KB from DNA. Transient transfec- 
tion studies have confirmed predictions that these IKB 
proteins can inhibit the ability of NF-KB subunits to ac- 
tivate transcription (Beg et al. 1992; Fujita et al. 1993). 
Therefore, it was quite surprising to find that the Bcl-3 
form of IKB leads to transcriptional activation through KB 
sites (Franzoso et al. 1992; Bours et al. 1993; Fujita et al. 
1993). Two distinct mechanisms have been proposed to 
explain the ability of Bcl-3 to activate transcription. One 
mechanism is through the association of Bcl-3 with p50 
homodimers (Franzoso et al. 1992), which may function 
as repressors of transcription from certain KB sites (Kang 
et al. 1992; Grilli et al. 1993). Cotransfection of Bcl-3 
with pS0 could potentially inhibit p50 homodimers from 
binding to r,B sites and thus allow p50-p65 or p65-p65 to 
interact with these sites, p65 contains a potent transcrip- 
tional activation domain leading to a dramatic increase 
in uanscription upon DNA binding. Therefore, in this 
case, Bcl-3 may act as an activator by functioning as the 
inhibitor of an inhibitor. 
The second mechanism by which Bcl-3 may act as a 
transcriptional activator is through the formation of a 
ternary complex with pS0 or p52 homodimers (p50B) 
bound to DNA (Bours et al. 1993; Fujita et al. 1993). 
Association of Bcl-3 with a p50-DNA or a p52-DNA 
complex results in the formation of a temary complex 
that can function as a strong transcriptional activator 
(Bours et al. 1993; Fujita et al. 1993). The transcriptional 
activation ability of this temary complex is likely medi- 
ated by the amino- and carboxy-terminal regions of Bcl-3 
(Bours et al. 1993; Fujita et al. 1993). The nuclear local- 
ization of Bcl-3 is consistent with its role as transcrip- 
tional coactivator. 
It is apparent that the proposed mechanisms by which 
Bcl-3 may activate transcription in the presence of p50 
are in seeming contradiction. Franzoso et al. (1992) sug- 
gest that Bcl-3 removes p50 from DNA, thus allowing 
p50-p65 to bind DNA, whereas Fujita et al. (1993} pro- 
vide evidence for a direct interaction between p50 and 
Bcl-3, thereby leading to transcriptional activation. A 
possible explanation for these differences has been pro- 
vided by Fujita et al. (1993) through the use of two dif- 
ferent p50 constructs for transfection studies with Bcl-3. 
A p50 construct, identical to the one used by Franzoso et 
al. (1992), encoding a protein of - 6 0  kD (and thus sig- 
nificantly larger than authentic p50), failed to synergize 
transcriptionally with Bcl-3 (Fujita et al. 1993). However, 
a protein that corresponds more closely to authentic p50 
was capable of synergism with Bcl-3, indicating that 
p105 residues carboxy-terminal to authentic p50 may 
prevent synergism with Bcl-3 (Fujita et al. 1993). These 
results indicate that the inhibition of p50 homodimer 
function by Bcl-3 may be attributable to the expression 
of a protein that does not correspond to authentic p50. It 
is important to note that the mechanisms proposed by 
both groups are based on results obtained by overexpres- 
sion of proteins in cell lines, although Fujita et al. (1993) 
have also demonstrated that p50 and Bcl-3 can synergize 
transcriptionally in vitro. However, conclusive proof for 
the existence of these mechanisms would require the 
identification of similar mechanisms at work in non- 
transfected cells. Other studies indicate (as mentioned 
previously) that Bcl-3 may inhibit p50 or p52 DNA bind- 
ing (Wulczyn et al. 1992; Nolan et al. 1993). It is likely 
that Bcl-3 may either remove p50 (or p52) homodimers 
from DNA or form ternary complexes with them, de- 
pending on the source of proteins used, relative concen- 
trations of proteins, post-translational modifications, 
and perhaps the KB sites being utilized. 
It has been shown recently that phosphorylated Bcl-3 
can interact with p50 more effectively than unphospho- 
rylated Bcl-3 (Nolan et al. 1993). Thus, phosphorylation 
of both the Bcl-3 and the IKBc~ proteins may lead to tran- 
scriptional activation by NF-KB. Phosphorylation of 
Bcl-3 may activate transcription through its association 
with p50 or p52 homodimers, whereas phosphorylation 
of IKBet may liberate cytoplasmic NF-KB, resulting in its 
nuclear translocation and the transcriptional activation 
of target genes bearing KB sites. 
Both p100/p52 and Bcl-3 are potential oncoproteins. 
The tumorigenic potential of p 100/p52 may be the result 
of the synthesis of a protein that contains the DNA- 
binding Rel domain but not the inhibitory carboxy-ter- 
minal ankyrin domain (Neri et al. 1991). The tumori- 
genic potential of Bcl-3, on the other hand, is likely me- 
diated through overexpression (Ohno et al. 1990). It is 
interesting that inappropriate expression of either one of 
these oncoproteins may have the same net effect of ac- 
tivating KB site-dependent transcription, suggesting that 
their oncogenic potential may lie in their ability to ele- 
vate expression of appropriate target genes. 
Conclusions 
It is clear from this discussion that association of IKBe~, 
IKBT, p 105, and p 100 with certain NF-KB subunits results 
in loss of their transcriptional activation function while 
association with Bcl-3 leads to the gain of that function 
(summarized in Fig. 1}. These observations challenge the 
notion that IKB proteins have an exclusively inhibitory 
function and suggest that they may be viewed more as 
modulators of NF-~J3 function rather than strictly as in- 
hibitors of NF-KB function. It remains to be determined 
whether p50-Bcl-3 or p52-Bcl-3 complexes are formed in 
response to particular developmental or extracellular sig- 
nals and what effect NF-KB inducers have on the forma- 
tion and dissociation of such complexes. Do agents that 
cause the loss of IKBa also affect Bcl-3, or is Bcl-3 regu- 
lated by a distinct set of signals? At this stage, it is not 
known whether the regulation of pS0 or p52 by Bcl-3 
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affects a d i s t inc t  class of KB s i te -conta in ing  target genes 
or w h e t h e r  Bcl-3 po ten t ia tes  the  ac t iva t ion  of genes tha t  
are already k n o w n  to be NF-~B responsive.  In any  case, 
the  m o d u l a t i o n  of NF-KB ac t iv i ty  by a m u l t i f u n c t i o n a l  
f ami ly  of IKB prote ins  suggests complex  m e c h a n i s m s  by 
w h i c h  NF-KB par t ic ipates  in  the  regula t ion  of a wide va- 
r ie ty  of genes tha t  are involved  in  key  biological  pro- 
cesses. 
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